Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Multiple sclerosis in 2013: Novel triggers, treatment targets and brain atrophy measures.
Safety and efficacy of reduced fingolimod dosage treatment.
Myelin damage and repair in pathologic CNS: challenges and prospects.
Oligodendrocyte Regeneration and CNS Remyelination Require TACE/ADAM17.
[Is it always useful to perform lumbar puncture for the diagnosis of multiple sclerosis? No].
Association between vestibulo-ocular reflex suppression, balance, gait, and fall risk in ageing and neurodegenerative disease: protocol of a one-year prospective follow-up study.
Opportunistic DNA Recombination with Epstein-Barr Virus at Sites of Control Region Rearrangements Mediating JC Virus Neurovirulence.
A case of classic neuromyelitis optica (Devic's syndrome) triggered by pegylated-interferon α.
Damping of monocular pendular nystagmus with vibration in a patient with multiple sclerosis.
Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy.
Spinal cord tumour misdiagnosed as seropositive neuromyelitis optica spectrum disorder.
Oral drugs in multiple sclerosis therapy: an overview and a critical appraisal.
Default Network Connectivity Is Linked to Memory Status in Multiple Sclerosis.
Activities of the European multiple sclerosis platform.
Pro-Inflammatory Cytokines Reduce the Proliferation of NG2 Cells and Increase Shedding of NG2 In Vivo and In Vitro.
Science to practice: myeloperoxidase immunoradiology improves detection of acute and chronic experimental multiple sclerosis.
The re-emergence of antigen-specific tolerance as a potential therapy for MS.
Exome sequencing identifies a novel, multiple sclerosis susceptibility variant in the TYK2 gene.
A case of acute disseminated encephalomyelitis disguised as mania in a woman with known bipolar disorder.
Transplanting of Mesenchymal Stem Cells May Affect Proliferation and Function of CD4+T Cells in Experimental Autoimmune Encephalomyelitis.
Strategies used by individuals with multiple sclerosis and with mild disability to maintain dynamic stability during a steering task.
Erratum to: Altered serotonin transporter availability in patients with multiple sclerosis.
SJL Mice Infected with Acanthamoeba castellanii Develop Central Nervous System Autoimmunity through the Generation of Cross-Reactive T Cells for Myelin Antigens.
The Olig family affects central nervous system development and disease.
Risk stratification and mitigation in multiple sclerosis.
Pages
« first
‹ previous
…
437
438
439
440
441
442
443
444
445
…
next ›
last »